Phase II Clinical Study of TR-012001 in Japanese Patients With Parkinson's Disease
Status:
COMPLETED
Trial end date:
2024-05-30
Target enrollment:
Participant gender:
Summary
The purpose of this study to evaluate the safety and pharmacokinetics of TR-012001 in patients with Parkinson's disease when TR-012001 or placebo is administered.